Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-12002017Phase 4Completed
Phase 4, open-label trial of anti-HPV biological protein in human papillomavirus infection (2 arms), sponsored by First Affiliated Hospital of Shanxi Medical University. Primary endpoint: HPV negative conversion rate. Started Mar 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-12002017.